The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...

The novel agent, along with standard second-line therapy, may allow patients to stay off treatment for longer periods and may ...

DURHAM, N.C. (WTVD) -- Global drugmaker, Novartis, is committed to North Carolina by expanding in three sites in the Research ...

Swiss pharmaceutical giant Novartis AG (NYSE:NVS) has entered into a massive $1.7 billion partnership with British ...

FDA Commissioner Marty Makary, North Carolina Governor Josh Stein and Novartis leadership highlight importance of new hub to US patients and ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

An investment worth $771 million is coming to Research Triangle Park with a massive pharmaceutical company’s expansion.

A Swiss drugmaker is breaking ground on new buildings in Durham. Novartis plans to spend hundreds of millions of dollars in ...

At the heart of the deal is Relation’s Lab-in-the-Loop platform, which uses AI models to improve understanding of diseases ...

A Swiss drugmaker is breaking ground on new buildings in Durham. Novartis plans to spend hundreds of millions of dollars in ...

Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Read more at The ...

"Novartis and UK-based Relation forge R&D deal worth up to $1.7bn" was originally created and published by Pharmaceutical ...